4/A//SEC Filing
Soares Karen 4/A
Accession 0001801170-25-000187
CIK 0001801170other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:07 PM ET
Size
7.8 KB
Accession
0001801170-25-000187
Insider Transaction Report
Form 4/AAmended
Soares Karen
General Counsel & Secretary
Transactions
- Award
Class A Common Stock
2024-09-13+518,000→ 1,515,032 total - Tax Payment
Class A Common Stock
2025-07-31$2.89/sh−38,086$110,069→ 1,476,946 total
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed to reflect the full number of RSUs that were achieved.
- [F2]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date.
- [F3]Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through July 31, 2025.
Documents
Issuer
CLOVER HEALTH INVESTMENTS, CORP. /DE
CIK 0001801170
Entity typeother
Related Parties
1- filerCIK 0001999086
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 5:07 PM ET
- Size
- 7.8 KB